back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-21 21:21 Tx date 2024-04-25 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,350
+490,000 vol $0.015 each |
1,355,000 | |
| Filed 2025-10-21 21:20 Tx date 2024-03-04 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,820
+391,000 vol $0.02 each |
865,000 | |
| Filed 2025-10-21 21:19 Tx date 2024-03-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15.00
+1,000 vol $0.015 each |
474,000 | |
| Filed 2025-10-21 21:18 Tx date 2024-02-29 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,620
+108,000 vol $0.015 each |
473,000 | |
| Filed 2025-10-21 21:17 Tx date 2023-10-30 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,250
+100,000 vol $0.0325 each |
365,000 | |
| Filed 2025-10-21 21:15 Tx date 2022-12-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,625
+265,000 vol $0.025 each |
265,000 | |
| Filed 2025-10-21 21:14 Tx date 2021-02-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Holder: L5 Capital Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-21 21:13 Tx date 2022-11-21 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,640
+88,000 vol $0.03 each |
7,016,666 | |
| Filed 2025-10-21 21:12 Tx date 2022-11-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360.00
+12,000 vol $0.03 each |
6,928,666 | |
| Filed 2024-05-16 00:42 Tx date 2020-12-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Clark, Chris
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-350,000 vol |
450,000 | |
| Filed 2024-05-16 00:39 Tx date 2024-05-09 |
$AQS
Aequus Pharmaceuticals Inc. |
Clark, Chris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,500
+150,000 vol $0.05 each |
750,000 | |
| Filed 2024-05-15 14:56 Tx date 2024-05-09 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Holder: Fehr & Associates (Indirect Ownership)
|
Options
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
350,000 | |
| Filed 2024-05-15 14:52 Tx date 2024-05-09 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,500
+150,000 vol $0.05 each |
725,000 | |
| Filed 2024-01-19 08:49 Tx date 2020-08-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-19 08:48 Tx date 2020-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
250,000 | |
| Filed 2024-01-19 08:45 Tx date 2023-04-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,500
+250,000 vol $0.03 each |
1,000,000 | |
| Filed 2024-01-19 08:43 Tx date 2023-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
1,250,000 | |
| Filed 2024-01-19 08:40 Tx date 2022-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
750,000 | |
| Filed 2024-01-19 08:39 Tx date 2021-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
500,000 | |
| Filed 2024-01-19 08:38 Tx date 2020-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |